In addition, studies indicated that SIRT3 can reduce ischemia-reperfusion injury and protect mitochondrial function by activating the anti-oxidant enzymes, suggesting that SIRT3 can be used to treat AKI ischemia-reperfusion injury (21). Here, SIRT3 is linked to acute kidney injury.